The Deal
The Deal podcast network brings The Deal’s award winning coverage in M&A, activist investing, private equity and restructuring to your airwaves. With a suite of offerings, including Activist Investing Today (hosted by Senior Editor Ronald Orol), Drinks With The Deal (hosted by Senior Writer David Marcus and Senior Reporter Bill Meagher), Behind The Buyouts (hosted by Senior Reporters Steve Gelsi, Nikitha Sattiraju and Senior Writer Chris Nolter) and Fresh Start (hosted by Senior Reporter Stephanie Gleason), The Deal’s podcast network is your go-to source for timely financial news and perspective.
Episodes
358 episodes
Behind the Buyouts: Huntington Bank's Wood on Capital Markets Expansion
Huntington Bank head of capital markets Chris Wood discusses its growth strategy, M&A trends and private equity dynamics.
Drinks With The Deal: Sidley's Khodadad on Road to PE
Sidley Austin's Mehdi Khodadad discusses how he pivoted to advising private equity clients as an associate and what he enjoys about the job.
Activist Investing Today: Pennant's Nowicki Stewart on AI Proxy Voting
Pennant founder and CEO Ryan Nowicki Stewart discusses AI-driven proxy voting, activism intelligence and market disruption.
Drinks With The Deal: Cooley's Proffitt on Leading Through Change
Cooley CEO Rachel Proffitt discusses her approach to leadership, talent management and lawyers' use of AI.
Behind the Buyouts: CCMP's McFadden on Middle Market Growth
CCMP Growth Advisors co-managing partner Mark McFadden discusses the firm's research-driven investing in the consumer and industrial markets.
Activist Investing Today: Sodali's Crawford, Dooley on Activism Intelligence
Sodali executives Aneliya Crawford and Bill Dooley discuss activist trends, investor behavior and AI-driven voting.
Behind the Buyouts: Unity Partners' Blankenau on Thematic Sourcing
Unity Partners head of business development Callie Blankenau discusses lower middle market investing and sourcing strategies.
Behind the Buyouts: Houlihan Lokey's Martin on Pharma Services Crossroads
Mark Martin, managing director and global head of pharma services and technology at Houlihan Lokey, discusses M&A momentum and investor sentiment in pharma services.
Drinks With The Deal: V&E's Fullenweider on Managing Difficult Conversations
Keith Fullenweider, chair of Vinson & Elkins, discusses the influence his father had on his career, how he built a PE practice, what he looks for in lateral hires and how he manages challenging conversations.
Activist Investing Today: S&C's Gadson on Proxy Advisers, AI
Sullivan & Cromwell partner Patrick Gadson discusses activism in banking and the shifting role of proxy advisers.
Behind the Buyouts: Macquarie's Velamati on Education's Expanding Horizons
Raghu Velamati, senior managing director at Macquarie Capital, discusses private equity's evolving approach to the education sector across lifelong learning, workforce training and school safety.
Behind the Buyouts: Hollander on GTCR's Growth-Driven Strategy
Mike Hollander, managing director at GTCR, discusses the firm's growth-oriented investment strategy and key deals across financial services and technology.
Drinks With The Deal: Akin’s Wollensack on How Nursing Prepared Her for PE
Akin PE partner Amy Wollensack discusses how a stint in nursing before law school helped her as a young lawyer and talks about talent management and AI.
Behind The Buyouts: Hivest’s Molin on Transatlantic Expansion
Hivest Capital Partners senior adviser Gregory Molin discusses the firm's value investing strategy and its cross-border approach to lower middle market M&A.
Drinks With The Deal: Hogan Lovells' Qureshi on Adjusting to New Environments
Mahvesh Qureshi, an M&A partner at Hogan Lovells and member of the firm's global board, discusses the social skills that have helped her succeed as a lawyer and law firm manager.
Activist Investing Today: Cleary’s Alsheimer Talks Activism Defense
Sebastian Alsheimer, who recently joined Cleary Gottlieb Steen & Hamilton as a partner and head of shareholder engagement, discussed AI in proxy voting, white squire strategies and M&A activism trends.
Drinks With The Deal: Greenberg Traurig's Levor on PE's Next Frontier
Shaun Levor of Greenberg Traurig discusses building a legal career in New York after growing up in South Africa and how his father, a trial lawyer, has influenced his approach to practice.
Activist Investing Today: V&E's Solorzano on Executive Order, Regulatory Shifts
Jon Solorzano, a partner at Vinson & Elkins, discusses how a sweeping White House executive order could drive changes to proxy advisers and shareholder proposals.
Drinks With The Deal: Vertex's Rughani on Corporate Development
Vertex head of corporate development Nigel Rughani discusses dealmaking, sourcing and integration strategy on the buy side.
Drinks With The Deal: Dechert's Thierfelder on Intensity in Practice, Management and Life
Dechert co-chair and PE and M&A partner Mark Thierfelder talks about embracing the intense nature of corporate practice, why lateral hiring is critical for his firm and his affinity for hobbies that force him to forget about work.
Behind The Buyouts: Jefferies’ Chu on Spectrum Strategy
Jefferies vice chairman Lawrence Chu discusses the $23 billion AT&T-EchoStar spectrum deal and the strategic landscape for wireless, fiber and AI infrastructure.
Drinks With The Deal: UIowa's Lie on Unmasking Corporate Fraud
University of Iowa finance professor Erik Lie discussed his pioneering research into options backdating, his new book Catching Cheats, and how forensic finance can detect hidden misconduct.
Behind The Buyouts: JPMorgan's Berkus on Consumer M&A Rebound
Bob Berkus, managing director on JPMorgan's investment banking team, discussed the firm's growing mid-cap unit and a strong pipeline of consumer and retail deals for 2026.
Activist Investing Today: Latham's Drewry, Dubofsky on Rising M&A Activism, Exxon Robo-Voting
Latham & Watkins partners Christopher Drewry and Josh Dubofsky, global co-chairs of the firm’s shareholder activism and takeover defense practice, discussed the latest trends in investor insurgencies on the Activist Investing Today podcast ...
